Where does Pangea Bio's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Pangea Bio's 1 recorded funding rounds.

Premier Alternatives

Pangea Bio

Drug Discovery · Kent, United Kingdom · Founded 2021 · Privately Held (backing)

Developer of a novel medicines platform designed to treat neurological disorders. Pangea Bio is based in Kent, United Kingdom and was founded in 2021. It was valued at $80 million at its early-stage round in Oct 2024, the last priced event on record. It has raised $21.7 million across 1 recorded round; the latest was a $15.6 million Series A in Oct 2023.

PMV mark · valuation

$80.0M

Oct 2026

Priced at

its early-stage round

Oct 2024

Total raised

$21.7M

Last round

Early Stage VC (Series A)

Oct 2023

Cap table — not yet on record

Pangea Bio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Pangea Bio with a free account

·The complete investor list: 19 names
·Watch Pangea Bio: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Pangea Bio

Where does Pangea Bio's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Pangea Bio's 1 recorded funding rounds.